Entelexo Biotherapeutics

Irvine, US · Founded 2020 · 3 employees · 1 known investors

Entelexo develops engineered exosome therapeutics for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. The company uses a proprietary platform to design exosomes that communicate with multiple diseased cell types simultaneously, replacing traditional single-target treatments.